DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United Kingdom
  • /
  • Healthcare
Author Program NEWCreate Narrative
CVSG logo

CVS Group plc Stock Price

LSE:CVSG Community·UK£876.8m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 29 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CVSG Share Price Performance

UK£0
-12.10 (-100.00%)
​
UK£16.40
Fair Value
UK£0
-12.10 (-100.00%)
​
Price UK£0
Wed, 24 Jun 26
Fair ValueUK£16.40
Share Pricen/a

CVSG Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value UK£16.4 21.3% undervalued intrinsic discount

CVSG: Shares Will Gain From Buyback Programme and Dividend Increase

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value UK£19.65 34.3% undervalued intrinsic discount

Rising Pet Ownership And Digital Integration Will Transform Veterinary Care

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value UK£13.4 3.7% undervalued intrinsic discount

Rising Costs And Regulatory Threats Will Erode Fundamentals

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CVSG logo
CVS Group
21.3% undervalued intrinsic discount

CVSG: Shares Will Gain From Buyback Programme and Dividend Increase

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 24 Jun
Read Narrative
CVSG logo
CVS Group
3.7% undervalued intrinsic discount

Rising Costs And Regulatory Threats Will Erode Fundamentals

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 22 May
Read Narrative
CVSG logo
CVS Group
34.3% undervalued intrinsic discount

Rising Pet Ownership And Digital Integration Will Transform Veterinary Care

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 13 Jul 2025
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
CVSG logo

CVSG: Share Buyback Momentum Will Support Future Upside Potential

Fair Value: UK£16.4 21.3% undervalued intrinsic discount
16 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
CVSG logo

CVSG: Neutral Coverage And Buyback Pressure Will Shape Future Earnings Profile

Fair Value: UK£13.4 3.7% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
CVSG logo

Rising Pet Ownership And Digital Integration Will Transform Veterinary Care

Fair Value: UK£19.65 34.3% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Good value with reasonable growth potential.

1 Risk
3 Rewards
View Full Analysis

CVS Group plc Key Details

UK£692.8m

Revenue

UK£393.2m

Cost of Revenue

UK£299.6m

Gross Profit

UK£283.1m

Other Expenses

UK£16.5m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Sep 24, 2026
0.24
43.24%
2.38%
56.9%
View Full Analysis

About CVSG

Founded
1999
Employees
9000
CEO
Richard William Fairman
WebsiteView website
www.cvsukltd.co.uk

CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products, as well as an online dispensary. In addition, the company provides veterinary instrumentation supply and property development services. The company was founded in 1999 and is headquartered in Diss, the United Kingdom.

Recent CVSG News & Updates

User avatar
Narrative Update • Jun 24

CVSG: Share Buyback Momentum Will Support Future Upside Potential

Analysts have kept their fair value estimate for CVS Group steady at £16.40, with small adjustments to assumptions such as the discount rate and future P/E leading to only a marginal change in the overall price target narrative. What’s in the News for CVS Group CVS Group commenced a share repurchase program on May 26, 2026, committing up to £50 million to buy back its shares.
User avatar
Narrative Update • Jun 06

CVSG: Activist Buyback Push And Index Inclusion Will Support Future Upside

Analysts have kept their £16.40 fair value estimate for CVS Group broadly unchanged, with a slightly higher discount rate and modest tweaks to revenue growth, profit margin and future P/E assumptions helping to frame a neutral stance following recent Street research. What's in the News Converium Capital Inc.

Recent updates

No updates

CVS Group plc Competitors

SPI logo

Spire Healthcare Group

Symbol: LSE:SPI
Market cap: UK£985.5m
AMS logo

Advanced Medical Solutions Group

Symbol: AIM:AMS
Market cap: UK£608.1m
CRW logo

Craneware

Symbol: AIM:CRW
Market cap: UK£443.8m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide